2024 Rome, Italy

III-48 Alejandro Pérez-Pitarch
Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes Mellitus: Modelling Rate and Severity of Hypoglycemic Events
Thursday 10:05-11:30